Stocklytics Platform
Pro-Dex
PDEX76
$55.19arrow_drop_up7.24%$3.72
NASDAQ - As of Apr 2, 7:12 PM EDT Market Closed
High Quality
High Growth
PDEX76

$55.19

arrow_drop_up7.24%

Performance History

arrow_drop_up202.41%

(+$36.94 )

Stocklytics logo
Key Stats
Open$52.61
Prev. Close$51.40
EPS1.96
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$179.88M
PE Ratio28.16
LOWHIGH
Day Range51.40
56.16
52 Week Range14.51
58.86
Ratios
P/B Ratio3.54
Revenue$53.84M
Operating M. %16.03%
Earnings$2.12M
Earnings Growth %-69.93%
EBITDA Margin %21.31%
ROE %21.22%
EPS1.96

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

Correlated Companies

Eli Lilly & Co
LLY84
Price$818.22
Perf. (24h)arrow_drop_down0.82%-$6.62
Market Cap$734.90B
UnitedHealth Group
UNH69
Price$523.20
Perf. (24h)arrow_drop_down0.78%-$4.12
Market Cap$483.13B
Johnson & Johnson
JNJ61
Price$155.36
Perf. (24h)arrow_drop_up1.39%$2.13
Market Cap$397.30B
AbbVie
ABBV67
Price$205.19
Perf. (24h)arrow_drop_down1.31%-$2.70
Market Cap$362.97B

About Pro-Dex (PDEX)

Pro-Dex Inc (PDEX) is a medical device company that designs, develops, and manufactures surgical and dental instruments. The company was founded in 1978 and is based in California. Pro-Dex's products are used by healthcare professionals in a variety of procedures, including orthopedic surgeries, neurosurgeries, and dental surgeries. The company's instruments are known for their precision and reliability, and they are trusted by doctors around the world. Pro-Dex has a long history of innovation and is constantly developing new technologies to improve surgical outcomes. The company's commitment to quality has earned it a reputation as a leader in the industry.
Pro-Dex Inc's stock price has seen some fluctuations over the years, but it has generally performed well. As of the latest data, the stock is trading at $12.50 per share. The stock has a 52-week range of $8.50 to $15.75, indicating some volatility in the market. Pro-Dex has a market cap of $100 million, making it a mid-sized company in the medical device industry. The company's PEG ratio is 1.5, which suggests that the stock is reasonably valued. Pro-Dex is trading at a price-to-earnings ratio of 15, which is slightly below the industry average.
Show more
Websitecall_made
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Mr. Richard Lee Van Kirk Jr.
Headquarters
Irvine
Employees
134
Exchange
NASDAQ
add Pro-Dex to watchlist

Keep an eye on Pro-Dex

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Pro-Dex 's (PDEX) price per share?

The current price per share for Pro-Dex (PDEX) is $55.19. The stock has seen a price change of $3.73 recently, indicating a 7.25% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Pro-Dex (PDEX)?

For Pro-Dex (PDEX), the 52-week high is $58.86, which is 6.65% from the current price. The 52-week low is $14.51, the current price is 280.36% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Pro-Dex (PDEX) a growth stock?

Pro-Dex (PDEX) has shown an average price growth of -1.65% over the past three years. It has received a score of 84 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Pro-Dex as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Pro-Dex (PDEX) stock price performance year to date (YTD)?

As of the latest data, Pro-Dex (PDEX) has a year-to-date price change of 18.05%. Over the past month, the stock has experienced a price change of 53.01%. Over the last three months, the change has been 19.05%. Over the past six months, the figure is 76.1%. Looking at a longer horizon, the five-year price change stands at 248.64%.
help

Is Pro-Dex (PDEX) a profitable company?

Pro-Dex (PDEX) has a net income of $2.13M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 27.02% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 16.03% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $53.84M, with a revenue growth rate of 16.83%, providing insight into the company's sales performance and growth. The gross profit is $14.55M. Operating income is noted at $7.17M. Furthermore, the EBITDA is $11.62M.
help

What is the market capitalization of Pro-Dex (PDEX)?

Pro-Dex (PDEX) has a market capitalization of $179.88M. The average daily trading volume is 55.08, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level